Report copyright - US Regulatory Perspective: Rare Tumors · 2018-12-13 · Regulatory endpoints • Measures of direct clinical benefit – Feels/Functions/Survives – Overall survival • Other/Surrogate
Please pass captcha verification before submit form
Please pass captcha verification before submit form